Company / R&D per Share
TransMedics Group, Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.05
FY2025
5-year range
$0.68 / $2.05
FY2021-FY2025
Trend
+19.9%
vs FY2024
Sector context
#46 of 108
Health Care
What the data says
At $2.05, TransMedics Group, Inc.'s r&d per share ranks #46 of 108 in the Health Care sector. R&D per Share has increased for 3 consecutive years, from $0.68 in FY2022 to $2.05 in FY2025.
Based on SEC 10-K filings.
2.05 in FY2025 with a 5-year CAGR of +8.0%.
Improved from $1.12 to $2.05 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +44.7%
- 5-Year CAGR
- +8.0%
- 10-Year CAGR
- -
Sector benchmark
In line with sector averageTop 43% of 108This company $2.05 Sector average $2.07
▼
In line with sector average
Key checks
Key Insights
- TransMedics Group, Inc.'s r&d per share has grown for 3 consecutive years.
- In FY2025, r&d per share increased 19.9% year-over-year.
- Ranks #46 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.05 | +19.9% |
| FY2024 | $1.71 | +52.7% |
| FY2023 | $1.12 | +65.6% |
| FY2022 | $0.68 | -2.2% |
| FY2021 | $0.69 | -50.5% |
| FY2020 | $1.40 | -86.3% |
| FY2019 | $10.22 | +0.0% |
| FY2018 | $10.22 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026